GHANA RECORDS ITS FIRST COVID-19 DELTA STRAIN.
Ghana has recorded its first Covid-19 Delta Strain. The Delta strain has been shown to be highly infectious. Delta strain variant is the most infectious Variant of Covid-19. The Covid-19 delta strain is most common in India.
It’s the most infectious of all the variants. So far India has recorded 30,183,143 cases of Covid-19 and 394,524 deaths. This delta variant was first discovered in India around December last year. The Covid-19 Delta Variant has so far spread to many countries.
The Delta Strain Virus was detected by travelers who arrived in Ghana. According to graphic.com.gh, A statement dated June 22, 2021, signed by the Director-General of Ghana Health Service(GHS), Dr. Patrick Kuma-Aboagye said on Tuesday night that Ghana has detected six Delta Strain Variant of the Covid-19 virus from all samples taken between April and June 2021 at the parts of the entry.
Dr. Patrick Kuma-Aboagye further stated that No Delta Variant has been detected from samples taken from cases in the community earlier on Tuesday in a radio interview monitored by Graphic Online on Accra based Citi FM, the Head of West Africa center for Cell Biology and infections Pathogens at the University of Ghana, Professor Gordon Awendare said Delta Variant was detected in two travelers who arrived from different countries at the Kotoka international airport in Accra he said.
It is only two people as of now. graphic.com.gh further stated that two people have since been quarantined and will continue to be on quarantine until they are negative. Furthermore, Prof Awendane said even though the Delta Strain Variant(Indian Variant) has been detected, it is not yet in the general population. The general population we still have mostly the U.K variant which is the Alpha Strain Variant.
So if you are deploying Sputnik and AstraZeneca. It is fine for now said Professor Awendane. The Indian Strain according to the world health organization (WHO) is the variant of concern; The variant was originally isolated in India but it has now spread across the world and is now the dominant strain in the United Kingdom and several African Countries, especially in East Africa.
As far as we know, it is not too different from the normal Covid-19 Delta Strain in terms of the clinical presentations Professor Awendare said. What is different in the genetic makeup is that it is more transmissible than the original variant. It means that if the original Covid-19 infected let’s say 10 people for each infected person, this one will infect maybe 17 or 18 people.
Professor Awendane said if you look at the data from all the different countries, it is the Pfizer vaccine that is able to have a more reliable effect on the newer variant in terms of all levels of protection- from hospitalization, from death, from infection.
According to the WHO, all viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’ properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or the performance of vaccines, therapeutic medicines, diagnostic tools, or other public health and social measures.
WHO, in collaboration with partners, expert networks, national authorities, institutions, and researchers have been monitoring and assessing the evolution of SARS-CoV-2 since January 2020. During late 2020, the emergence of variants that posed an increased risk to global public health prompted the characterization of specific Variants of Interest (VOIs) and Variants of Concern (VOCs), in order to prioritize global monitoring and research, and ultimately to inform the ongoing response to the COVID-19 pandemic.
WHO and its international networks of experts are monitoring changes to the virus so that if significant mutations are identified, countries and the public can be informed about any changes needed to react to the variant, and prevent its spread. Globally, systems have been established and are being strengthened to detect “signals” of potential VOIs or VOCs and assess these based on the risk posed to global public health.
The Pfizer vaccine seems to be doing better with this new variant in those different levels of protection, He said. But Professor Awendane stressed that all the other vaccines give assurance of protection against hospitalization, from death, severe disease, and infection. He said different vaccines provide levels of protection.